“
Zymeworks Inc.
ManojNair · March 2, 2026
Zymeworks Inc. (NASDAQ: ZYME), a Canada-based mostly scientific-stage biotechnology firm, on Monday reported a wider net loss for the fourth quarter of fiscal 2025, reflecting a pointy decline in revenues.
Source link
#Earnings #Abstract #Zymeworks #ZYME #FY25 #net #loss #widens #AlphaStreet #News
